Open AccessMyocardial contrast echocardiography for the distinction of hypertrophic cardiomyopathy from athlete's heart and hypertensive heart disease
Author(s) -
Andreas Indermühle
Publication year - 2009
Publication title -
swiss medical weekly
Language(s) - English
Resource type - Journals
eISSN - 1424-7860
pISSN - 1424-3997
DOI - 10.4414/smw.2009.12775
Subject(s) - medicine , hyperaemia , hypertrophic cardiomyopathy , hypertensive heart disease , cardiology , left ventricular hypertrophy , muscle hypertrophy , cardiomyopathy , blood flow , heart failure , blood pressure
Myocardial contrast echocardiography (MCE) is able to measure in vivo relative blood volume (rBV, i.e., capillary density), and its exchange frequency b, the constituents of myo-cardial blood flow (MBF, ml min-1 g-1). This study aimed to assess, by MCE, whether left ventricular hypertrophy (LVH) in hypertrophic cardiomyopathy (HCM) can be differentiated from LVH in triathletes (athlete's heart, AH) or from hypertensive heart disease patients (HHD).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom